News
After twelve months of successful immersive Limud HaTorah with Chayus and Simcha, Kitos Daled, Hey, Vov, and Zayen of Cheder ...
Q2 Revenue Growth of 2.5%, Currency Neutral Growth of 1.8%Q2 Annual Subscription Revenue Growth of 3.7%, Currency Neutral 3.0 ...
Positive interim Phase 1b update underscores firmonertinib's potential in EGFR PACC mutant NSCLC; global pivotal Phase 3 ALPACCA study expected to enroll first patient in 2H 2025Dosed the first patien ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback